Skip to main content
. 2024 Oct 22;25(21):11366. doi: 10.3390/ijms252111366

Figure 9.

Figure 9

The expression of Skp2 was reduced by PAO, PhAs-LHP, and gemcitabine. Tumor tissues from the experiments shown in Figure 5 and Figure 6 were immunohistochemically stained by Skp2. The expression of Skp2 was decreased in the tumors of mice treated with PAO, PhAs-LHP, and gemcitabine. The combination of gemcitabine with PAO or PhAs-LHP did not further decrease the levels of Skp2. *, p < 0.05 compared to the untreated control. CT, control; Gem, gemcitabine.